Clinical trials
Medical Treatment clinical trials
Below are recruiting medical treatment clinical trials, each written for real people, not researchers. We’re tracking 1,055 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07134985Recruiting
Children who leave the ER without being seen
This study looks at why some children leave the emergency department before getting treatment. It may help improve care for families.
HaderaAges Up to 17 years - NCT07091734RecruitingPhase 2
Tirzepatide for partial lipodystrophy: a new treatment study
This trial is testing a medication called tirzepatide (Mounjaro) to see if it can help people with a rare fat disorder called familial partial lipodystrophy. The study hopes to improve blood sugar control and lower triglycerides, which are often high in this condition.
Ann Arbor, MichiganAges 18 years+ - NCT07051694Recruiting
Ear nerve stimulation for sepsis patients in the ICU
This trial tests a non-invasive ear stimulation device (taVNS) as an extra treatment for sepsis in the ICU. It may help reduce inflammation and improve recovery.
ChongqingAges 18–80 - NCT06960655Enrolling by invitation
Improving heart disease treatment and cholesterol care
This program aims to improve how doctors manage cholesterol and other treatments for people with heart or blood vessel disease. It focuses on patients who also have diabetes or a genetic high-cholesterol condition, and are seen at Mass General Brigham.
Boston, MassachusettsAges 18–95 - NCT06834191Recruiting
Parkinson's and immunosuppressant drugs study
This study looks at how taking immunosuppressive medicines affects the course of Parkinson's disease. It compares people with Parkinson's who have been on these drugs for over a year to those who have never taken them regularly.
WarsawAges Any age - NCT05925023Recruiting
Sirolimus for warm autoimmune hemolytic anemia after steroid failure
This trial studies sirolimus in adults with “warm” autoimmune hemolytic anemia (or Evans syndrome) when steroids have not worked or the anemia has returned. It may help control the immune attack on red blood cells, but there are specific safety checks for liver health and infections.
Beijing, Beijing MunicipalityAges 18–90 - NCT06539234Recruiting
Angiotensin II test for treating vasoplegic shock
This trial tests a medicine called angiotensin II to see how well it helps people whose blood pressure stays dangerously low after standard treatments for vasoplegic shock, a condition where blood vessels relax too much. If it works, it might help raise blood pressure and improve blood flow to vital organs.
MariborAges 18 years+ - NCT06281756RecruitingEarly Phase 1
CBT and Trazodone for Sleep and Blood Pressure in Insomnia
This trial tests whether cognitive behavioral therapy (a type of talk therapy for sleep) and/or the medication trazodone can improve sleep and lower blood pressure in people with chronic insomnia. You must be 18 or older and have ongoing trouble sleeping.
Denver, ColoradoAges 18 years+ - NCT04190862RecruitingPhase 1
Cell therapy for simple anal fistulas
This Phase 1 study tests whether a donated-cell treatment (given with a minor procedure) can help heal simple anal fistulas. It mainly focuses on safety first, but may also look at how well the fistula closes.
New York, New YorkAges 18 years+ - NCT06025500Recruiting
Muscle function before and after lung valve treatment
This study looks at how well your leg muscles work before and after getting special valves placed in your lungs. It uses an exercise bike test and an MRI scan to measure muscle changes, and the results may help people with COPD breathe better.
GroningenAges Any age - NCT05781555Recruiting
DaRT radiation device study for treating tumors
This study tests a radiation-emitting device (called DaRT) for treating cancer tumors. It may help shrink or control malignant tumors and researchers will check safety and response to the treatment.
JerusalemAges 18 years+ - NCT04745728RecruitingPhase 3
Testing different immune-suppressing treatments for membranous kidney disease
This Phase 3 trial compares different immune-suppressing medicines for idiopathic membranous nephropathy (a kidney disease caused by the immune system). It may help reduce heavy protein leakage in the urine and improve disease control in people who fit specific prior-treatment and lab requirements.
Beijing, Beijing MunicipalityAges 18–80 - NCT05019495Recruiting
Study to improve quit-smoking support for people with HIV
This trial tests ways to deliver tobacco-quit treatment more effectively for people living with HIV. You may help researchers compare different quit-support approaches to see what works best.
Charleston, South CarolinaAges 21 years+ - NCT04743765Recruiting
Faster hip fracture care for people with heart stress signs
This study looks at an “accelerated” hospital plan to get surgery and treatment started sooner for some people with a hip fracture who also show signs of heart stress in blood tests. It may help reduce delays and improve safety during urgent hip fracture care.
Chandler, ArizonaAges 45 years+ - NCT04263285Recruiting
Repetitive brain stimulation for depression after spinal cord injury
This trial studies a brain-stimulation treatment to improve depression symptoms in people who have depression after a spinal cord injury. It may help if you have major depression and meet specific safety and eligibility checks.
Charleston, South CarolinaAges 18–70 - NCT07126678Recruiting
Zanubrutinib, Bendamustine, and Obinutuzumab for advanced follicular lymphoma
This trial tests a 3-drug combination (Zanubrutinib, Bendamustine, and Obinutuzumab) for people with advanced follicular lymphoma who have not had treatment before. The goal is to see if a fixed-duration treatment plan can improve outcomes.
Nanjing, JiangsuAges 18–75 - NCT07039604Recruiting
Real-world study of PADN for pulmonary artery hypertension
This study tracks how well a procedure called PADN works for people with pulmonary artery hypertension (PAH) in real-life medical settings. PADN is a minimally invasive treatment that targets nerves around the lungs to help lower blood pressure in the arteries.
Nanjing, JiangsuAges Any age - NCT04020510RecruitingPhase 4
Standard versus fewer bladder Botox injections for overactive bladder
This study compares the usual amount of Botox injected into the bladder versus a smaller amount. It aims to see whether fewer injections can reduce overactive bladder symptoms with fewer side effects, like trouble emptying the bladder.
Bethesda, MarylandAges 18 years+ - NCT06463847RecruitingPhase 1
Stem cell therapy for knee osteoarthritis
This trial tests a new stem cell treatment (UC-MSCs) for knee osteoarthritis. It aims to see if this treatment is safe and can help reduce pain and improve knee function.
Wuhan, HubeiAges 50–70 - NCT07605715Recruiting
Catheter vs. Surgery for Leaky Mitral Valve
This study compares two ways to fix a leaky mitral valve (a heart valve that doesn't close properly): one using a thin tube inserted through blood vessels (catheter) versus traditional open-heart surgery. The goal is to see which approach works better and is safer for older adults.
Los Angeles, CaliforniaAges 60 years+ - NCT07554092Recruiting
Fast vs. Standard Casting for Baby Club Foot Treatment
This study compares two ways of treating club foot (a condition where a baby's foot is twisted inward at birth) using casts: a faster method and the traditional method. It will measure which approach works better using X-rays to see how well the foot straightens.
Peshawar, KPKAges 1 day–5 months - NCT06774209Recruiting
Imaging study for pelvic tumors using PET and MRI
This study uses special PET scans to better see and understand pelvic tumors. It may help doctors plan treatment more accurately. You may be able to join if you have a pelvic tumor and can have surgery or a biopsy.
Beijing, Beijing MunicipalityAges 18–70 - NCT07453342Recruiting
Safety of immunotherapy side effects and restarting treatment
This study looks at patients who had side effects from cancer immunotherapy (checkpoint inhibitors). The goal is to understand those side effects and whether it is safe to restart immunotherapy after they resolve.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07414342Recruiting
Study of RENATUS® valve for severe aortic stenosis
This study tests a new device called the RENATUS® Transcatheter Aortic Valve System for people with severe aortic stenosis. It is designed to replace the narrowed valve without open-heart surgery, and aims to see if it is safe and effective for patients with various surgical risk levels.
BeijingAges 60–100
Hear when a new Medical Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for medical treatment?
- Yes. Clin2 currently lists 1,055 recruiting medical treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a medical treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a medical treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.